Aikaterini Teli
Overview
Explore the profile of Aikaterini Teli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zarkada E, Yfanti E, Teli A, Balassopoulou A, Sinopoulou K, Theodoridou S
Hemoglobin
. 2022 Aug;
46(2):140-142.
PMID: 36000573
We report the hematological data of the codon 7 (AG>AG (: c.22G>T) mutation for the first time in two Albanian individuals from the region of Elbasan, who underwent genetic testing...
2.
Efstathiou A, Boutou E, Teli A, Drikos I, Balassopoulou A, Theodoridou S
Hemoglobin
. 2022 Aug;
46(2):132-136.
PMID: 36000508
The rare hemoglobin (Hb) variant Hb Natal [α140(HC2)Tyr-Arg→0 (: c.423C>A)], detected on the α2-globin gene, is characterized by a shortened polypeptide chain because of a premature stop codon formation in...
3.
Dritsa M, Economou M, Perifanis V, Teli A, Christoforidis A
Acta Haematol
. 2022 Mar;
148(1):1-7.
PMID: 35235930
Background: Current guidelines recommend yearly evaluation of glucose metabolism with oral glucose tolerance test (OGTT) in patients with thalassemia major (TM) from their 10th year onwards. Aims: The aim of...
4.
Adramerina A, Printza N, Hatzipantelis E, Symeonidis S, Tarazi L, Teli A, et al.
Biology (Basel)
. 2022 Feb;
11(2).
PMID: 35205113
Thalassemic syndromes are characterized by clinical heterogenicity. For severe disease forms, lifelong blood transfusions remain the mainstay of therapy, while iron overload monitoring and adequate chelation treatment are required in...
5.
Adramerina A, Teli A, Symeonidis S, Gelsis I, Gourtsa V, Economou M
J Pediatr Hematol Oncol
. 2021 Sep;
44(5):237-242.
PMID: 34486567
Hemophilia is characterized by bleeding diathesis, primarily affecting the joints. Prophylactic use of missing factor aims at limiting the number of bleeds and, in the long term, the risk of...
6.
Stabouli S, Antza C, Papadopoulou E, Teli A, Kotsis V, Economou M
J Clin Hypertens (Greenwich)
. 2020 Aug;
22(8):1444-1449.
PMID: 32762124
Sickle cell disease (SCD) is associated with increased risk of cardiovascular disease, although blood pressure (BP) levels have been reported to be lower in SCD patients compared to general population....
7.
Theodoridou S, Prapas N, Balassopoulou A, Boutou E, Vyzantiadis T, Adamidou D, et al.
Hemoglobin
. 2018 Dec;
42(4):257-263.
PMID: 30501529
Hemoglobinopathies constitute the most frequent monogenic disorders worldwide and in Greece. In Greece, carrier frequency is estimated at about 8.0%, resulting in a heavy disease burden in the past. Therefore,...
8.
Theodoridou S, Teli A, Yfanti E, Vyzantiadis T, Theodoridis T, Economou M
Hemoglobin
. 2018 Jul;
42(2):129-131.
PMID: 30025477
Hb Adana (HBA2: c.179G>A) is found worldwide but is extremely rare and carriers are asymptomatic, with red cell indices similar to α-thalassemia (α-thal) carriers. First line screening tests are unable...
9.
Economou M, Teli A, Gourtsa V, Vargiami E, Zafeiriou D
J Pediatr Hematol Oncol
. 2016 May;
38(5):406.
PMID: 27164520
No abstract available.
10.
Efthimia V, Neokleous N, Agapidou A, Economou M, Vetsiou E, Teli A, et al.
Ann Hematol
. 2012 Aug;
92(2):263-5.
PMID: 22933235
No abstract available.